Levi & Korsinsky announces it has commenced an investigation of Spero Therapeutics Inc. (NASDAQ: SPRO) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.
Required Field
There is no cost or obligation for you to submit.
The submission of this form does not create an attorney-client relationship.